{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:42:31Z","timestamp":1782823351946,"version":"3.54.5"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute (NCI)","doi-asserted-by":"publisher","award":["N01-CP-11005"],"award-info":[{"award-number":["N01-CP-11005"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["FDA BB-IND 7920"],"award-info":[{"award-number":["FDA BB-IND 7920"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1093\/jnci\/djx158","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T15:11:20Z","timestamp":1499267480000},"page":"205-212","source":"Crossref","is-referenced-by-count":77,"title":["Durability of Protection Afforded by Fewer Doses of the HPV16\/18 Vaccine: The CVT Trial"],"prefix":"10.1093","volume":"110","author":[{"given":"Mahboobeh","family":"Safaeian","sequence":"first","affiliation":[{"name":"Roche Molecular Diagnostics, Pleasanton, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua N.","family":"Sampson","sequence":"additional","affiliation":[{"name":"National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanji","family":"Pan","sequence":"additional","affiliation":[{"name":"HPV Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Porras","sequence":"additional","affiliation":[{"name":"Agencia Costarricense de Investigaciones Biom\u00e9dicas (ACIB), formerly Proyecto Epidemiol\u00f3gico Guanacaste, Fundaci\u00f3n INCIENSA, San Jos\u00e9, Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy J.","family":"Kemp","sequence":"additional","affiliation":[{"name":"HPV Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Herrero","sequence":"additional","affiliation":[{"name":"Prevention and Implementation Group, International Agency for Research on Cancer, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Quint","sequence":"additional","affiliation":[{"name":"DDL, Diagnostic Laboratory, Rijswijk, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen Jan","family":"van Doorn","sequence":"additional","affiliation":[{"name":"DDL, Diagnostic Laboratory, Rijswijk, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Schussler","sequence":"additional","affiliation":[{"name":"Information Management Systems, Silver Spring, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Lowy","sequence":"additional","affiliation":[{"name":"National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Schiller","sequence":"additional","affiliation":[{"name":"National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Schiffman","sequence":"additional","affiliation":[{"name":"National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cecilia","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Agencia Costarricense de Investigaciones Biom\u00e9dicas (ACIB), formerly Proyecto Epidemiol\u00f3gico Guanacaste, Fundaci\u00f3n INCIENSA, San Jos\u00e9, Costa Rica"},{"name":"Independent Consultant, San Jos\u00e9, Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell H.","family":"Gail","sequence":"additional","affiliation":[{"name":"National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Hildesheim","sequence":"additional","affiliation":[{"name":"National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Agencia Costarricense de Investigaciones Biom\u00e9dicas (ACIB), formerly Proyecto Epidemiol\u00f3gico Guanacaste, Fundaci\u00f3n INCIENSA, San Jos\u00e9, Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia A.","family":"Pinto","sequence":"additional","affiliation":[{"name":"HPV Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aim\u00e9e R.","family":"Kreimer","sequence":"additional","affiliation":[{"name":"National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Costa Rica HPV Vaccine Trial (CVT) Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonz\u00e1lez","family":"Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia E.","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cecilia","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Hildesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aim\u00e9e R.","family":"Kreimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Lowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sholom","family":"Wacholder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia A.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy J.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Sidawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen-Jan","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Struijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Palefsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa M.","family":"Darragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Stoler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,8,28]]},"reference":[{"issue":"12","key":"key\n\t\t\t\t20181003112228_djx158-B1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer."},{"issue":"RR-2","key":"key\n\t\t\t\t20181003112228_djx158-B2","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep."},{"issue":"4","key":"key\n\t\t\t\t20181003112228_djx158-B3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: Biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"issue":"7","key":"key\n\t\t\t\t20181003112228_djx158-B4","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: A pooled analysis","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Glob Health."},{"issue":"17","key":"key\n\t\t\t\t20181003112228_djx158-B5","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2013.1625","article-title":"Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: A randomized clinical trial","volume":"309","author":"Dobson","year":"2013","journal-title":"JAMA."},{"issue":"12","key":"key\n\t\t\t\t20181003112228_djx158-B6","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4161\/hv.7.12.18322","article-title":"Immunogenicity and safety of the HPV-16\/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: Results from","volume":"7","author":"Romanowski","year":"2011","journal-title":"a randomized study. Hum Vaccin."},{"key":"key\n\t\t\t\t20181003112228_djx158-B7","first-page":"465","volume-title":"Weekly Epidemiological Record","author":"World Health Organization","year":"2014"},{"key":"key\n\t\t\t\t20181003112228_djx158-B8","volume-title":"Fewer Shots Offer More Incentive to Prevent HPV Cancers","author":"Centers for Disease Control and Prevention","year":"2016"},{"key":"key\n\t\t\t\t20181003112228_djx158-B9","volume-title":"The World Health Organization's (WHO) Strategic Advisory Group of Experts (SAGE).","author":"World Health Organization","year":"2016"},{"issue":"19","key":"key\n\t\t\t\t20181003112228_djx158-B10","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/jnci\/djr319","article-title":"Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16\/18 vaccine","volume":"103","author":"Kreimer","year":"2011","journal-title":"J Natl Cancer Inst."},{"issue":"7","key":"key\n\t\t\t\t20181003112228_djx158-B11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1470-2045(15)00047-9","article-title":"Efficacy of fewer than three doses of an HPV-16\/18 AS04-adjuvanted vaccine: Combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials","volume":"16","author":"Kreimer","year":"2015","journal-title":"Lancet Oncol."},{"issue":"11","key":"key\n\t\t\t\t20181003112228_djx158-B12","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1158\/1940-6207.CAPR-13-0203","article-title":"Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial","volume":"6","author":"Safaeian","year":"2013","journal-title":"Cancer Prev Res (Phila)."},{"issue":"1","key":"key\n\t\t\t\t20181003112228_djx158-B13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1470-2045(15)00414-3","article-title":"Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: A multicentre prospective cohort study","volume":"17","author":"Sankaranarayanan","year":"2016","journal-title":"Lancet Oncol."},{"issue":"5","key":"key\n\t\t\t\t20181003112228_djx158-B14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/infdis\/jiw227","article-title":"Comparison of 2-dose and 3-dose 9-valent human papillomavirus vaccine schedules in the United States: A cost-effectiveness analysis","volume":"214","author":"Laprise","year":"2016","journal-title":"J Infect Dis."},{"issue":"37","key":"key\n\t\t\t\t20181003112228_djx158-B15","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1016\/j.vaccine.2008.07.002","article-title":"Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica","volume":"26","author":"Herrero","year":"2008","journal-title":"Vaccine."},{"issue":"18","key":"key\n\t\t\t\t20181003112228_djx158-B16","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.vaccine.2015.03.015","article-title":"Rationale and design of a long term follow-up study of women who did and did not receive HPV 16\/18 vaccination in Guanacaste, Costa Rica","volume":"33","author":"Gonzalez","year":"2015","journal-title":"Vaccine."},{"issue":"6","key":"key\n\t\t\t\t20181003112228_djx158-B17","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0002-9440(10)65688-X","article-title":"Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses","volume":"153","author":"Kleter","year":"1998","journal-title":"Am J Pathol."},{"issue":"8","key":"key\n\t\t\t\t20181003112228_djx158-B18","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/JCM.37.8.2508-2517.1999","article-title":"Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus","volume":"37","author":"Kleter","year":"1999","journal-title":"J Clin Microbiol."},{"issue":"9","key":"key\n\t\t\t\t20181003112228_djx158-B19","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1128\/JCM.00539-06","article-title":"Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR","volume":"44","author":"van Doorn","year":"2006","journal-title":"J Clin Microbiol."},{"issue":"6","key":"key\n\t\t\t\t20181003112228_djx158-B20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4161\/hv.4.6.6912","article-title":"Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16\/18 cervical cancer vaccine","volume":"4","author":"Dessy","year":"2008","journal-title":"Hum Vaccin."},{"issue":"7","key":"key\n\t\t\t\t20181003112228_djx158-B21","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4161\/hv.24340","article-title":"Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: Results from the Costa Rica Vaccine Trial","volume":"9","author":"Safaeian","year":"2013","journal-title":"Hum Vaccin Immunother."},{"key":"key\n\t\t\t\t20181003112228_djx158-B22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00912.x","article-title":"Mechanisms that determine plasma cell lifespan and the duration of humoral immunity","volume":"236","author":"Amanna","year":"2010","journal-title":"Immunol Rev."},{"issue":"3","key":"key\n\t\t\t\t20181003112228_djx158-B23","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju436","article-title":"The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents","volume":"107","author":"Kreimer","year":"2015","journal-title":"J Natl Cancer Inst."},{"issue":"9","key":"key\n\t\t\t\t20181003112228_djx158-B24","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/infdis\/jiu648","article-title":"Raising expectations for subunit vaccine","volume":"211","author":"Schiller","year":"2015","journal-title":"J Infect Dis."}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/110\/2\/205\/25894819\/djx158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T12:19:42Z","timestamp":1602418782000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/110\/2\/205\/4096545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,28]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,8,28]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djx158","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.731392928.793538644","asserted-by":"object"}]},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,8,28]]}}}